Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
cough; exhaustion; sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced sickness (Verbatim: sick), cough (Verbatim: cough) and exhaustion (Verbatim: exhaustion). The outcome of the sickness was resolved (duration 1 week) and the outcome of the cough and exhaustion were not reported. It was unknown if the reporter considered the sickness, cough and exhaustion to be related to RSV vaccine. It was unknown if the company considered the sickness, cough and exhaustion to be related to RSV vaccine. Additional Information: GSK Receipt Date: 18-JUN-2025 This case was reported by a patient via interactive digital media. Patient had gotten the vaccine the previous fall, but the emergency room told him/her he/she had RSV. Patient had been sick for over a week, and he/she finally went to the emergency room because his/her cough and exhaustion had gotten really bad. The vaccine had not completely prevented the illness, just like the COVID vaccine had not been perfect.